Abstract P311, an 8-kDa polypeptide, was previously shown to be highly expressed in invasive glioma cells. Here, we report the functional characteristics of P311 with regard to influencing glioma cell migration. P311 is constitutively serine-phosphorylated; decreased phosphorylation is observed in migration-activated glioma cells. The primary amino acid sequence of P311 indicates a putative serine phosphorylation site (S59) near the PEST domain. Site-directed mutagenesis of S59A retarded P311 degradation and induced glioma cell motility. In contrast, S59D mutation resulted in the rapid degradation of P311 and reduced glioma cell migration. Coimmunoprecipitation coupled with matrixassisted laser desorption/ionization time-of-flight mass spectrometry analysis identified Filamin A as a binding partner of P311, and immunofluorescence studies showed that both proteins colocalized at the cell periphery. Moreover, P311-induced cell migration was abrogated by inhibition of b1 integrin function using TACb1 A , a dominant-negative inhibitor of b1 integrin signaling, suggesting that P311 acts downstream of b1 signaling. Finally, overexpression of P311 or P311 S59A mutant protein activates Rac1 GTPase; small interfering RNA -mediated depletion of Rac1 suppresses P311-induced motility. Collectively, these results suggest a role for levels of P311 in regulating glioma motility and invasion through the reorganization of actin cytoskeleton at the cell periphery. Neoplasia (2005) 7, 862 -872
Introduction
Glioblastoma multiforme (GBM) is the most common primary malignant tumor of the adult central nervous system and has a median survival time of < 1 year. The highly lethal nature of this tumor partly derives from the acquisition of an invasive phenotype, which allows the tumor cells to infiltrate surrounding brain tissues [1, 2] . Accordingly, localized treatments of GBM are palliative, but there is lack of success in eradicating this invasive disease. Consequently, identification and characterization of proteins that drive the invasive behavior of GBM may serve as reliable diagnostic and prognostic markers, as well as potential targets for effective therapy.
Gene expression profiling using mRNA differential display and cDNA-based microarrays has been used to identify the spectrum of genes differentially expressed coincident to glioma migration [3, 4] . Among these invasion-regulated genes was P311 (PTZ17) [5] . P311 codes for an 8-kDa intracytoplasmic protein initially identified in neurons and muscles [6] . P311's amino acid sequence contains a conserved PEST domain (Pro, Glu, Ser, and Thr) [7] , which plays a role in targeting proteins for degradation by the ubiquitin/proteasome system or plays a function in protein -protein interactions [8] . The rapid decay of P311 protein has been described in both smooth muscle and neural cells [9] . The half-life of P311 is 5 minutes or less, with the rapid degradation being directed by the ubiquitin/ proteasome system and an unidentified metalloprotease [9] .
The identification of P311 as a glioma invasion candidate gene is supported by expression levels that correlate with glioma motility [5] . Antisense oligonucleotides downregulated P311 mRNA and protein levels, and resulted in the reduction of glioma cell migration. Immunohistochemical staining of human glioblastoma specimens indicated elevated staining of P311 in glioma cells at the invasive edge of the tumor, compared to the absent expression in normal brain cells [5] .
In this study, the role of P311 protein and its potential interactions with the cytoskeleton as a mediator and/or prognostic marker of glioma invasion are described. Overexpression of P311 enhances glioma cell motility; P311 activity and stability are regulated by the phosphorylation of serine 59 located near the PEST domain. Site-directed mutagenesis of S59A stabilizes the P311 protein and induces glioma cell migration. In addition, immunoprecipitation coupled with matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis identified Filamin A (a b1 integrin actin binding protein that regulates cell motility) as a P311 binding partner. Both P311 and Filamin A colocalize at the leading edge of migrating glioma cells, and overexpression of P311 induces Rac1 activation. Depletion of Rac1 expression by small interfering RNA (siRNA) oligonucleotides abrogates P311-induced migration. Thus, these results indicate that P311 may function in the reorganization of the actin cytoskeleton at the cell periphery necessary for cell migration and that P311-induced cell migration and protein stability are dependent on S59 phosphorylation.
Materials and Methods

Cell Culture Conditions and Extracellular Matrix (ECM) Preparation
Human glioma cell lines G112 [10] , SF767 [11] , T98G, and U118MG (American Type Culture Collection, Manassas, VA) were maintained in minimum essential medium (MEM; Invitrogen Corp., Carlsbad, CA) supplemented with 10% heatinactivated fetal bovine serum (FBS; Hyclone Laboratories, Inc., Logan, UT) in a 37jC, 5% CO 2 atmosphere at constant humidity. U118 -P311-FLAG and U118 vector-only stably transfected glioma cells (Dr. Gregory Taylor; Duke University, Durham, NC) were cultured under G418 selection (200 mg/ml) in MEM supplemented with 10% heat-inactivated FBS in a 37jC, 5% CO 2 atmosphere at constant humidity. Gliomaderived ECM was prepared as previously described [11] .
Radial Cell Migration Assay
Quantification of cellular migration was performed using a microliter scale migration assay [12] . Approximately 2000 cells were plated onto 10-well slides precoated with glioma-derived ECM using a cell sedimentation manifold (CSM, Inc., Phoenix, AZ) to establish a confluent 1-mmdiameter monolayer. Cells were allowed to disperse for 24 to 48 hours. Measurements were taken of the area occupied by the cells at regular intervals over 48 hours. The average migration rate of 10 replicates was calculated as the increasing radius of the entire cell population over time.
Site-Directed Mutagenesis and Adenovirus Production and Infection
P311 cDNA (pRcCMV, human P311) was excised and ligated into pcDNA3.1 (Invitrogen Corp.) using HindIII and ApaI. Mutagenic primers were designed specifically for the region of the gene-flanking serine codon 59 (TCC) as follows: GCC (coding for alanine), GAC (coding for aspartate), and GAG (coding for glutamate) ( Table 1 ). The Quick Change Kit (Stratagene, La Jolla, CA) was used according to the manufacturer's instructions on copying this region of the gene. These primers were designed: to flank the site of mutation by 10 to 15 bases, to have a 62.5% GC content, to terminate in one or more G or C bases, and to have a calculated melting temperature of 82.1jC as per manufacturer's instructions. After the primers were used to generate double-stranded copies of the plasmid containing mutated P311 insert, the original vector/insert DNA was digested using DpnI to destroy the methylated parental template, leaving a new circular, nicked dsDNA copy of the plasmid containing the mutated gene of interest. This plasmid was transformed into XL-1 Blue supercompetent cells to repair the nicks in the mutated plasmid. The cells were scaled up, and new plasmids were isolated for subsequent transformation or shuttling into mammalian expression vectors containing a CMV promoter for the transformation of glioblastoma cells with the mutated P311 gene.
Primers were designed to add the FLAG sequence and to incorporate an XhoI restriction site to the existing plasmids (forward 5V-CAG AAT TCC GGA CCA TGG TTT ATT ACC CAG AAC TCT TT-3V and reverse 5V-CAT CTA GAC TGA TGT TCC TGC TGC TAC TGT TCA TCA GAT CTA C-3V). All sequences were verified by DNA sequencing. Restriction digestion using XhoI and BglII was performed to subclone the plasmids into the pShuttle-CMV to prepare recombinant E1-deleted adenoviruses using the Ad-Easy system, as described [13] . Viruses were propagated in HEK 293 cells (ATCC CRL 1573), clonally isolated, and titered as previously described [14] . Dominant-negative TACb1 A integrin adenoviral construct [15] was obtained from Dr. Joseph Loftus (Mayo Clinic, Scottsdale, AZ). Cells were infected at matched multiplicity of infection (MOI), as noted in the Results section.
Antibodies and Immunoblotting
A mouse monoclonal antibody, anti -FLAG M2, was obtained from Eastman Kodak Co. (Rochester, NY). Polyclonal anti-FLAG antibodies were purchased from Sigma (St. Louis, MO). Monoclonal antibodies to the human b1 integrin subunit were purchased from Chemicon International (Temecula, CA). Polyclonal antibodies to phosphoserine were obtained from Zymed (South San Francisco, CA). Monoclonal antibodies to protein kinase C (PKC)~and polyclonal antibodies specific to PKCa, PKCb1, PKCy, PKCq, and PKCg were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Monoclonal antibodies to alpha tubulin were purchased from Upstate Biotechnology (Lake Placid, NY). Anti -mouse IgG and anti -rabbit IgG antibodies coupled to horseradish peroxidase (HRP) were purchased from Promega (Madison, WI). Immunoblotting and protein determination experiments were preformed as previously described [16] . Briefly, cells were washed in phosphatebuffered saline (PBS) containing 1 mM phenylmethylsulfonyl fluoride (PMSF), as described above. The cells were then lysed in 2Â sodium dodecyl sulfate (SDS) sample buffer (0.25 M Tris -HCl, pH 6.8, 2% SDS, and 25% glycerol) containing 10 mg/ml aprotinin, 10 mg/ml leupeptin, 0.7 mg/ml pepstatin, 20 mM NaF, and 1 mM PMSF. Protein concentrations were determined using the BCA assay procedure (Pierce, Rockford, IL), with bovine serum albumin as a standard. Thirty micrograms of total cellular protein was loaded per lane, separated by 12% SDS polyacrylamide gel electrophoresis (PAGE) or 16% Tricine gels for P311 analysis, and then transferred to nitrocellulose (Schleichter&Schuell, Keene, NH) by electroblotting. The nitrocellulose membrane was blocked with 5% nonfat dry milk in Tris-buffered saline (pH 8.0) with 0.1% Tween-20 prior to addition of the primary antibody and then HRP-conjugated anti -mouse/rabbit IgG (Promega). Bound secondary antibodies were detected using a chemiluminescence system (NEN Life Science Products, Boston, MA). Densitometric analysis of the bands was conducted using Scion Image.
PKC Inhibitors and Phosphatase Inhibitors
Cells were plated at 50% confluency. PKC-specific inhibitor bisindolylmaleimide-1 (BIM-1), Go6976, or R0-32-0432 was added to the cells 30 minutes prior to cell lysis at 10 mM-an IC 50 that has been previously shown to inhibit selective PKC isoforms [17] . BIM-1 inhibits classic Ca 2+ -dependent PKC isoforms a and bI, as well as novel PKC isoforms y, q, and~with this same ranked order of potency [18] . Go6976 inhibits PKC with particular specificity for the classic PKC isoforms a, bI, and bII but also for atypical PKCm [19] , whereas Ro-32-0432 selectively inhibits isoforms a and bI [20] . In certain experiments, Calyculin A (20 nM) and okadaic acid (100 nM) were added to cells 30 minutes prior to cell lysis to inhibit protein phosphatases PP1 and PP2A, respectively. Each experiment was performed in triplicate.
Immunofluorescence Microscopy Cells were grown on 10-well glass slides previously coated with glioma-derived ECM until they reached about 50% confluency, fixed for 5 minutes in 4% paraformalydehyde in PBS. Cells were then permeabilized with 0.1% Triton X-100 in PBS. After washing with PBS, cells were blocked with 1% bovine serum albumin and 3% goat serum, and incubated with primary antibody for 1 hour at 25jC. Following washing with 0.1% BSA in PBS and incubation with Cy3-conjugated anti -mouse IgG or fluorescein isothiocyanateconjugated antirabbit Ig, cell nuclei were stained with 4V, 6-diamidino-2-phenylindole (DAPI) from (Sigma) in PBS for 15 minutes at 37jC, and mounted with SlowFade from Molecular Probes (Eugene OR). Immunofluorescent samples were examined under a laser scanning confocal microscope (LSM 410) equipped with helium, neon, and argon lasers (Zeiss, Thorton, NY) using appropriate filters.
Immunoprecipitation and MALDI-TOF MS
Cells were plated onto 60-mm plates, grown to 70% confluency, and, in certain experiments, labeled in Cys/ Met -free Dulbecco's modified Eagle's medium (Invitrogen Corp.) supplemented with 10% FBS (vol/vol) and 0. Products). Prior to lysis, cells were incubated for 30 minutes with lactacystin (10 mm) and o-phenanthroline (1.26 mM) to block P311 proteosome degradation [9] , or left untreated. Cell were washed in PBS containing 1 mM PMSF and then lysed in NP40 buffer (10 mM Tris -HCl, pH 7.4, 0.5% Nonidet P-40, 150 mM NaCl, 1 mM PMSF, 1 mM EDTA, 2 mM sodium vanadate, 10 mg/ml aprotinin, and 10 mg/ml leupeptin). Protein concentrations were determined using the BCA assay procedure (Pierce), with bovine serum albumin as a standard. Equivalent amounts of proteins were precleared and immunoprecipitated from the lysates, and washed with lysis buffer followed by S1 buffer (10 mM HEPES, pH 7.4, 0.15 M NaCl, 2 mM EDTA, 1.5% Triton X-100, 0.5% deoxycholate, and 0.2% SDS) (Tran NL 2002) . Samples were resuspended in 2Â SDS sample buffer (0.25 M Tris -HCl, pH 6.8, 2% SDS, and 25% glycerol) and boiled in the presence of 2-mercaptoethanol (Sigma). Samples were separated on 16% tricine gels and silver-stained or blotted onto nitrocellulose for immunoblot analysis. For MALDI-TOF MS, protein bands were stained with the silver stain kit from (Bio-Rad, Hercules, CA) [21] . Briefly, proteins in gels were fixed with 50% methanol and 10% acetic acid, then oxidized in a solution of potassium dichromate in diluted nitric acid, washed with water, and treated with silver nitrate solution. Color development was stopped with 5% acetic acid once the desired staining intensity had been achieved. Unique bands were excised from the gel and washed twice in 100 nM NH 4 HCO 3 buffer, followed by soaked in 100% acetonitrile for 5 minutes, aspiration of the acetonitrile, and drying for 30 minutes. After rehydration of the pellet, the proteins were digested using 20 mg/ml trypsin (Promega) suspended in 25 mM NH 4 HCO 3 buffer, incubated at 37jC for 20 hours, and dried under vacuum. Trifluoroacetic acid (TFA) (5%, 120 ml) was added to the tube and incubated at 40jC for 1 hour in a water bath. After collecting the supernatant, another 120 ml of TFA solution (2.5% TFA and 50% acetonitrile) was added to the tube and incubated at 30jC for 1 hour in a water bath. The supernatants were combined and dried to a powder under vacuum. The samples of generated peptides were dissolved in 5 ml of 0.5% TFA and measured by MALDI-TOF MS analysis at the University of Arizona Proteomic Core Facility (Tucson, AZ). Data searches were performed using the NCBI protein data bank with a minimum matching peptide setting of four, a mass tolerance setting of 50 to 200 ppm, and a single trypsin miss cut setting.
siRNA Preparation and Transfection siRNA oligonucleotides specific for Rac1 and GL2 luciferase were previously described [22] . siRNA oligonucleotides specific for PKCa, PKCq, and PKC~were designed according to Elbashir et al. [23] and purchased from Qiagen (Valencia, CA). siRNA sequences to PKC isoforms used were: PKCa (regions 494 -514, 5V-CTG CGG AAT GGA TCA CAC TGA), PKCq (regions 2631 -2651, 5V-AAC TCA TTG GGT CAG CAA TTA), and PKC~(regions 482 -502, 5V-AAC GGG AGA AGA CAA ATC TAT). Transient transfection of siRNA was carried out using Lipofectamine 2000 (Invitrogen Corp.) according to the manufacturer's protocol. Cells were plated in a six-well plate at 2.0 Â 10 5 cells/well in 1.5 ml of MEM, supplemented with 10% serum without antibiotics. Transfections were carried out according to the manufacturer's protocol after cells were fully spread (6 hours postplating). Cells were infected with Rac1 siRNA oligonucleotides at a concentration of 20 nM, and PKCa, PKCq, and PKCs iRNA oligonucleotides at a concentration of 40 nM. No cell toxicity was observed at these concentrations of siRNA. Using quantitative PCR, we verified that the siRNA oligonucleotides to PKCa, PKCq, and PKC~specifically inhibited the expression of PKCa, PKCq, and PKC~, respectively. In addition, Rac1 siRNA was previously shown to specifically inhibit the expression of Rac1 [22] . Maximum inhibition was achieved by days 2 to 3 after transfection, and cells were assayed on day 3 or day 4 posttransfection.
Rac1 and Cdc42 Activity Assays
The activity assays for Rac1 and Cdc42 were performed according to the manufacturer's protocol (Pierce). Briefly, equal numbers of cells were seeded and infected with the P311 wild-type (wt) or mutant adenoviral constructs. Cells were serum-starved for 16 hours, lysed, and centrifuged for 10 minutes. The supernatant (500 mg of protein) was added to 20 mg of glutathione S-transferase (GST) human p21-activated kinase 1 (Pak1) binding, rotated at 4jC for 1 hour, and followed by three washes of protein complexes with lysis buffer. Pak1-bound proteins were dissociated and denatured by heating in sample buffer at 98jC for 5 minutes and subjected to gel electrophoresis. Bound proteins were visualized using either anti -Rac1 or anti -Cdc42 antibody (Pierce) and chemiluminescence techniques.
Results
P311 Enhances Glioma Cell Migration and Localizes at the Leading Edge of Cell Migration
Previous data from antisense oligonucleotide studies suggested that P311 plays a role in migrating glioma cells [5] . To examine the effect of P311 expression on cell migration, stably expressing P311 -FLAG -tagged U118 glioma cells and their matched vector controls were deposited using a cell sedimentation manifold onto 10-well glass slides previously coated with glioma-derived ECM [24] . Glioma-derived ECM has been previously shown to enhance the motility behavior of these cells [4, 24] . The U118 -P311 -FLAG -tagged glioma cells migrated one and a half times faster than the vector-only control cells ( Figure 1A ). P311-transfected glioma cells show a reduction of stress fiber actin cytoskeleton compared to controls and an increase in cortical actin deposits ( Figure 1B, a and d) . In addition, immunocytochemistry revealed P311 localization at the leading edge of cell migration ( Figure 1B) . Thus, the data corroborate the previous study suggesting that overexpression of P311 induces glioma cell motility.
Actively Migrating Glioma Cells Display Decreased Serine Phosphorylation of P311
Analysis of P311 amino sequence using the Expert Protein Analysis System (ExPASy) Prosite proteomics database (http://au.expasy.org/prosite/) predicted that codon 59 serine is a putative PKC phosphorylation site. U118 glioma cells respond to different substrates with different migration behaviors. On glioma-derived ECM, the cells migrate, whereas on standard tissue culture, plastic cell motility is minimal. Cells were grown either on unmodified culture dishes (stationary nonmotile) or in flasks precoated with glioma-derived ECM (migration-promoting environment). Total cellular lysates were prepared, and P311 was immunoprecipitated using an anti -FLAG M2 antibody, followed by an immunoblot analysis for phosphoserine. Serine phosphorylation of P311 was two-fold higher for stationary cells compared to cells plated on a motility-activating substrate (Figure 2A) , suggesting that phosphorylation modification of P311 accompanies glioma cell motility. To control for effects related to the composition of the ECM, we examined the serine phosphorylation levels of P311 in glioma cells plated on glioma-derived ECM at high cell density, which prevents cell movement, and at low density, which promotes cell motility. A three-fold decrease of serine phosphorylation was detected in actively migrating glioma cells compared to migration-restricted cells on the identical substrate ( Figure 2B ). This suggests that altered serine phosphorylation of P311 is, in part, a migration-associated effect.
Because a putative PKC phosphorylation site is identified at codon 59 of P311, we investigated whether the serine phosphorylation of P311 is a consequence of PKC activation. Western blot analysis from four glioma cell lines revealed differential expression of various PKC isoforms in the different glioma cell lines ( Figure 2C ). Specifically in U118 cells, PKCa and PKCq are expressed at high levels, and PKCb1 and PKC~are detected at moderate levels, whereas minimal expression of PKCg and PKCy was detected ( Figure 2C) . The activity of different PKC family members was targeted using selective PKC inhibitors Go6976, Ro-32-0432, and BIM-1 [18 -20] . U118 cells were grown sparsely on standard tissue culture flasks then treated with the various PKC inhibitors at 10 mM concentration. P311 was immunoprecipitated from cell lysates using anti -FLAG M2 antibodies. Western blot analysis using specific antiphosphoserine antibodies showed that serine phosphorylation of P311 was reduced three-fold in the presence of BIM-1 ( Figure 2D ; cf. lanes A and E ). Additionally, no phosphorylation changes were affected by Go6976 and Ro-32-0432 ( Figure 2D, lanes F and G, respectively) . Moreover, because decreased serine phosphorylation is observed in migrating glioma cells, we examined the effect of specific phosphatase inhibitors of PP1 and PP2A [17] . Treatment of cells cultured on glioma-derived ECM with Calyculin A (Figure 2D , lane c) and okadaic acid ( Figure 2D, lane d) prevented the loss of Figure 2 . Actively migrating cells display reduced serine phosphorylation of P311. (A) U118 -P311 -FLAG -transfected cells were cultured on tissue culture plastic (P) or glioma-derived ECM (E). Cells were then preincubated with proteosome inhibitors lactacystin and o-phenanthroline for 30 minutes prior to cell lysis. P311 was immunoprecipitated with an anti -FLAG M2 antibody and immunoblotted with phosphorylated serine or FLAG M2 -specific antibodies. Relative protein densities of P311 phosphoserine to total P311 ratio were determined. Each relative protein value was further normalized to the P311 phosphorylation levels in cells cultured on tissue culture plastic. Data represent the average of three independent experiments. (B) U118 -P311 -FLAG -transfected cells were cultured on glioma-derived ECM at high cell density (1 Â 10 5 cells/cm 2 ; D, dense) or low cell density (1 Â 10 4 cells/cm 2 ; S, sparse), and phosphoserine levels of P311 were evaluated as described above. (C) Immunoblot analysis of various PKC isoforms on whole cell lysates from four glioma cell lines. (D) U118 -P311 -FLAGtransfected cells were cultured on tissue culture plastic (P) or glioma-derived ECM (E). Cells were then incubated with the indicated PKC inhibitors at 10 M or solvent DMSO control and proteosome inhibitors for 30 minutes prior to cell lysis, and phosphoserine levels of P311 were evaluated as described above.
P311 serine phosphorylation levels compared to solvent treatment ( Figure 2D, lane b) . These outcomes suggest a role for phosphatases such as PP1 or PP2A in P311 activity, and further support the regulated serine phosphorylation of P311 impacting the migration of glioma cells.
siRNA-Mediated Depletion of PKCq and PKC~Results in Loss of P311 Serine Phoshorylation
The effect of BIM-1 on P311 suggests that the novel class of PKC isoforms, particularly y, q, and~, may play a role in P311 serine phosphorylation. Because PKCq and PKC~are detected in U118 cells, we examined whether these two isoforms are critical for the serine phosphorylation of P311. siRNA oligonucleotide duplexes were specifically designed against either PKCa, PKCq, or PKC~. The degree of protein knockdown in U118 -P311 -FLAG -tagged glioma cells was f85% to 90%, as verified by Western blot analysis using antibodies specific to either PKCa ( Figure 3A) , PKCq ( Figure 3B ), or PKC~( Figure 3C ). As expected, high serine phosphorylation of P311 was detected in migration-restricted cells ( Figure 3D, lane a) , whereas decreased levels of P311 serine phosphorylation were detected in migration-activated cells ( Figure 3D, lane b) . Interestingly, siRNA-mediated depletion of either PKCq ( Figure 3D, lane d ) or PKC( Figure 3D , lane e) resulted in a decrease in P311 serine phosphorylation in migration-restricted cells, whereas no loss of P311 serine phosphorylation was detected in PKCa-depleted cells. Taken together, our results show that the serine phosphorylation of P311 is dependent on the function of both PKCq and PKC~.
Serine Phosphorylation at S59 Is Important for P311-Induced Cell Migration and P311 Protein Stability
To determine whether serine phosphorylation at S59 of P311 influences migration, site-directed mutants of P311 were generated and propagated into replication-deficient adenoviruses ( Figure 4A ). Each construct also contained a FLAG epitope at the carboxyl terminus. Alanine (S59A) Figure 3 . Depletion of either PKCe or PKCn inhibits P311 serine phosphorylation in migration-restricted cells. Western blot analysis determining the protein expression of PKCa (A), PKCe (B), and PKCf (C) after siRNA transfection, as described in Materials and Methods. (D) U118 -P311 -FLAGtagged cells were plated on either tissue culture plastic (P) or glioma-derived ECM (E). Cells were then transfected with siRNA directed against either PKCa, PKCe, PKCf, or control luciferase (ctrl siRNA), and cultured for an additional 24 hours. Proteosome inhibitors were then added 30 minutes prior to cell lysis, and P311 was immunoprecipitated with an anti -FLAG M2 antibody and immunoblotted for phosphorylated serine or FLAG M2 -specific antibodies. 
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substitution was constructed to eliminate phosphorylation at S59, whereas aspartate (S59D) and glutamate (S59E) were designed to mimic a constitutively phosphorylated serine at S59 ( Figure 4A ). U118 glioma cells infected with varying MOIs of P311wt showed a titer-dependent induction of the P311 protein ( Figure 4B ). In addition, expression of all mutated constructs was verified by immunoblot analysis for the FLAG epitope (MOI = 20; Figure 4C ). The substitution of P311 S59 for S59A, S59D, and S59E eliminated the detection of any serine phosphorylation ( Figure 4D ), demonstrating that S59 is the only active phosphoregulated serine in P311.
To determine the effect of P311 S59 mutations on glioma cell migration, we examined the migratory capacity of cells expressing either wild-type or phosphorylation site mutants of P311. Cells expressing wild-type P311 or the S59A mutant displayed enhanced migration rates in four different glioma cell lines, ranging from 1.4-to 2-fold induction ( Figure 5A ). Glioma cells expressing P311 S59D or S59E mutants showed a decreased migration rate relative to uninfected or LacZ-infected controls ( Figure 5A ). These results indicate that glioma cell migration, in part, requires serine phosphorylation of P311 and that serine phosphorylation of P311 at S59 is a potential mediator of P311-regulated glioma cell migration.
A previous study by Taylor et al. [9] showed that P311 was targeted for degradation by multiple proteolytic pathways, including the ubiquitin/proteasome pathway, resulting in an extremely short protein half-life. Because S59 is flanked by a PEST sequence, we investigated the effect of the S59 mutational substitution on P311 protein stability. U118 glioma cells were infected with the adenoviral P311 mutant constructs and cultured in the presence or absence of the proteosome inhibitors lactacystin and o-phenanthroline. Whole cell lysates were collected and immunoblotted for anti-FLAG M2. In the absence of proteosome inhibitors, P311wt was rapidly degraded ( Figure 5B ). Blocking the ubiquitin/proteosome degradation pathway resulted in a nearly two-fold rise in P311wt protein levels. In contrast, the levels of P311 S59A and S59E mutants were unaffected by the absence of the proteosome inhibitors; the P311 S59D mutant showed degradation of the protein, similar to P311wt ( Figure 5B ). The stability of the P311wt and each P311 mutant protein was observed in the presence of the ubiquitin/proteosome inhibitors. Confirmation of the effect of S59 mutations on P311 protein stability was performed by 35 S methionine labeling of proteins in U118 cells. Densitometric analysis of the autoradiogram revealed an approximately two-fold ( P < .001) increase in the protein stability of P311 S59A and S59E compared to P311wt and S59A mutant in the absence of the ubiquitin/proteosome inhibitor (data not shown).
Identification of Filamin A as a Binding Partner to P311
Because P311 is not a member of any known family of proteins, clues suggesting function based on analogy are not available. To determine possible mechanisms by which P311 regulates cell migration, we sought potential binding partners of P311 in an immunoprecipitation pulldown experiment coupled with MALDI-TOF MS analysis. U118 -P311 cells were cultured under migration-restricted or migrationactivated states. Total cellular lysates were prepared and P311 protein was immunoprecipitated using an anti -FLAG M2 epitope antibody. Coimmunoprecipitated proteins accompanying P311 showing differential abundance under migration-restricted or migration-activated states were detected on a standard one-dimensional SDS-PAGE system ( Figure 6A ). Three putative P311-binding proteins were uniquely detected in migration-activated glioma cells. Band 2 was a contaminant and band 3 was identified by MALDI-TOF MS analysis as a GAPDH homolog protein. Interestingly, band 1, a 230-kDa protein, was identified as Filamin A, a b1 integrin cytoskeletal-binding protein ( Figure 6A ). Coimmunoprecipitation of P311 with Filamin A was verified by immunoprecipitation with a Filamin A antibody, suggesting that Filamin A interacts with P311. Interestingly, Filamin A immunoprecipitation studies showed that P311 binds equally to Filamin A in migration-activated and migration-restricted cells ( Figure 6B ). To further confirm the association of P311 with Filamin A, P311 and Filamin A were immunolocalized in glioma cells. P311 immunofluorescence showed strong localization at the leading edge of cell migration in lamellipodial structures as anticipated ( Figure 6C ; panel e, arrow). When cells were coimmunolabeled for Filamin A and P311, Filamin A was also detected at the leading edge of cell migration ( Figure 6C; panel d, arrowhead ) . Merging of the two confocal images revealed identical patterns of colocalization ( Figure 6C ; panel f, asterisk). Thus, these data support an association between the two proteins, P311 and Filamin A.
Inhibition of 1 Integrin Function Suppresses P311-Induced Cell Motility
b1 Integrin has been previously shown to play a role in glioma cell motility and invasion [25 -28] ; blocking b1 integrin function resulted in decreased glioma adhesion and migration [26, 27] . Because Filamin A is a cytoskeletal protein that interacts with the b1 integrin, we investigated whether the inhibition of b1 integrin function by a dominant-negative b1 protein, TACb1 A , would suppress P311-induced cell motility. The TACb1 A chimeric receptor contains the b1 integrin intracellular domain coupled to a reporter consisting of the transmembrane and extracellular domains of the small, nonsignaling subunit of the interleukin-2 receptor [29] . TACb1 A was previously shown to disrupt b1 integrin adhesion and signaling [15, 29] . Expression of the TACb1 A protein in U118 cells resulted in a two-fold decrease in cell migration on glioma-derived ECM compared to LacZ-infected control ( Figure 7A ). As expected, overexpression of P311wt enhances glioma migration ( Figure 7A ). However, coexpression of P311wt and TACb1 A suppresses P311-induced cell migration, suggesting that regulation of P311-induced cell motility is dependent on functional b1 integrins.
We next determined whether interfering with the b1 integrin function by TACb1 A expression alters P311 serine phosphorylation status. U118 -P311 glioma cells plated U118 -P311 -FLAG -transfected cells were infected with adenoviruses expressing TAC1 A or control LacZ, and cultured for 24 hours. Cells were then cultured on tissue culture plastic or glioma-derived ECM, and phosphoserine levels of P311 were evaluated as described above.
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sparsely or densely on glioma-derived ECM were infected with adenoviruses expressing dominant-negative TACb1 A integrin or control TACa5 integrin. Cells infected with control LacZ showed a decrease in P311 serine phosphorylation levels in migration-stimulated cells compared to migrationrestricted cells ( Figure 7B ). However, disruption of b1 integrin function by TACb1 A not only inhibited the loss of P311 serine phosphorylation in migration-activated glioma cells, but appeared to lead to hyperphosphorylation of P311 ( Figure 7B ). These data support the notion that P311-induced migration is dependent on b1 integrin function.
P311-Induced Glioma Migration Is Dependent on Rac1 Activation
The small GTPase, Rac1, is important for the migration and invasion of tumor cells [30, 31] . Because P311 is localized at the cell periphery, we sought to determine whether P311-induced glioma migration is dependent on Rac1 activation. We examined the effect of P311wt and mutant proteins on Rac1 activation. For these experiments, we utilized the Rac1-binding domain of Pak1 fused to GST to affinity-precipitate active Rac1 [32, 33] . Cells infected with either P311wt or P311 S59A showed high Rac1 activation compared to uninfected cells or control cells (LacZ infection) ( Figure 8A ). No Rac1 activation was detected in cells infected with P311 S59D and P311 S59E. Immunoprecipitation results indicated that Rac1 does not directly associate with P311 (data not shown), arguing for other intermediate regulatory proteins serving as activating links between P311 and Rac1. In addition, overexpression of P311wt or P311 S59A had no effect on Cdc42 activation (data not shown). Specific siRNA oligonucleotides knocked down endogenous Rac1 protein by f90% ( Figure 8B ) and suppressed glioma migration ( Figure 8C, lane c) . Interestingly, Rac1 depletion abrogated P311wt-and P311 S59A -induced cell motility (cf. lanes g versus i and j versus l ); luciferase control siRNA had no effect on P311-induced cell migration (lanes h and k) . These results suggest that P311-induced cell migration is dependent on Rac1.
Discussion
To date, the function of P311 in glioma biology is unknown. P311 has been previously characterized by the presence of a conserved PEST domain that is targeted by the ubiquitin/ proteosome system, resulting in a protein half-life of about 5 minutes [7] . In this study, we demonstrated the importance of the phosphorylation on S59 in the regulation and stability of P311 in glioma cells. The phosphorylation status of S59 is largely dependent on upstream PKC activity and active cell motility. Mutational analysis of S59 indicates that this serine residue is the solitary active phosphoserine within P311. Consequently, mutation of P311 S59A resulted in loss of P311 serine phosphorylation, heightened stability of the P311 protein, and induction of glioma cell migration.
Regulation of cell migration is a dynamic process involving, among other reactions, modulation of focal adhesion dynamics and actomyosin polymerization and contraction [34, 35] . Currently, it is not known how P311 participates in the regulation of cell migration. Comparative analysis of P311 serine phosphorylation status indicated that glioma cells actively migrating on glioma-derived ECM displayed a reduction in P311 serine phosphorylation. This decreased level of serine phosphorylation appears to be independent of the glioma-derived ECM because migration-restricted confluent glioma cells on glioma-derived ECM also demonstrated a decreased level in P311 serine phosphorylation (data not shown). Accordingly, mutation of P311 S59A results in the loss of serine phosphorylation and an enhanced cellular migration similar to overexpression of the P311wt protein. In contrast, both S59E and S59D mutations did not change cell motility. The difference between alanine substitution and aspartate and glutamate substitution is that both aspartate and glutamate substitutions were designed to mimic a constitutive phosphorylated serine by weight and charge, suggesting that the phosphorylated serine residue regulates P311-induced cell migration. The findings in this Figure 8 . P311 overexpression induces Rac1 activation, and depletion of Rac1 inhibits P311-induced cell migration (A). U118 cells were infected with P311wt or P311 mutant adenoviruses (NI, no infection). Cells extracts were assayed for Rac1 activation using the PBD assay, as described in Materials and Methods. (B) Western blot analysis determining the protein expression of Rac1 after siRNA transfection, as described in Materials and Methods. NT, no transfection. (C) U118 cells were transfected with siRNA directed against control luciferase (trl siRNA) or Rac1. Cells were then infected with adenoviruses expressing control LacZ, P311wt, or P311 S59A. Cell migration was assessed on glioma-derived ECM over 48 hours.
report support this interpretation. In addition, maintenance of P311 in its dephosphorylated form is dependent on b1 integrin signaling, as indicated by maintenance of a constant (elevated) level of serine phosphorylation when TACb1 A is expressed, which inhibits b1 integrin function. Inhibition of b1 integrin signaling also abrogated P311-induced cell migration, suggesting that P311 acts in concert with signaling that is downstream of b1 integrin.
Site-directed mutagenesis of S59A prevents the P311 protein from being degraded by ubiquitin-mediated proteolysis. Interestingly, although the P311 S59E mutant did not enhance glioma motility, protein stability was similar to the P311 S59A mutant, whereas P311 S59D resulted in rapid ubiquitin-mediated proteolysis. It is likely that tertiary protein conformations from the site-directed mutants may explain the differential binding of ubiquitin proteins to the PEST sequence. Interestingly, pharmacologic inhibitor data suggest that a novel class of PKC isoforms, particularly y, q, and , regulates P311 serine phosphorylation status. In the present study, BIM-1 reduced P311 serine phosphorylation, whereas Go6976 and Ro-32-0432 had no effect. BIM-1 inhibits the y, q, and~isoforms of PKC, distinct from the other inhibitors [18] . PKC activity has been correlated with growth rates [36, 37] and migration behavior [38 -40] in gliomas in vitro. Specifically, PKCq has been shown to positively regulate b1 integrin-dependent adhesion, spreading, and motility of human glioma cells [40] . In fact, the current findings support the notion that both PKCq and PKCã re upstream mediators of P311 serine phosphorylation. Depletion of either PKCq or PKC~expression resulted in the loss of P311 serine phosphorylation in migration-restricted glioma cells. However, P311 serine phosphorylation is not completely abrogated by BIM-1 treatment or siRNA depletion of PKCq or PKC~, suggesting that other signaling pathways besides PKC are involved in P311 serine phosphorylation.
Immunoprecipitation of P311, coupled with MALI-TOF MS analysis, revealed that Filamin A is directly or indirectly a binding partner of P311. Filamin A is a large actin-binding protein that stabilizes three-dimensional actin webs. Filamin A links the actin cytoskeleton to cellular membranes, thereby regulating cellular, architectural, and signaling functions essential for cell motility [41] . Filamin A binds to at least 20 other marcromolecules, including b1 integrin [42] , which has been shown to play a crucial role in glioma cell migration and invasion [25, 27, 28] and has multiple functions, including its role in cortical stability necessary for lamellipodial extension and cell crawling [43] . We demonstrated that P311 and Filamin A colocalize at the leading edge of migrating glioma cells and that both P311 and Filamin A are localized at lamellipodial structures, suggesting a possible influence on the activity of the small GTPase, Rac1. We report that overexpression of P311 in glioma cells induces Rac1 activation. Notably, activation of Rac1 occurs through the exchange of bound GDP for GTP, catalyzed by one of multiple Rac guanine exchange factors (GEFs) [44] . Likewise, inhibition of Rac1 expression by siRNA oligonucleotides suppresses P311-induced migration. It is possible that P311 may modulate cytoskeleton dynamics by influencing one of the Rac GEF proteins involved in Rac1 activation and subsequently regulating cell migration. In fact, Rac1 has been shown to play an important role in various malignant carcinoma cells and in gliomas [22, 30, 45] . Interestingly, immunoprecipitation studies showed no evidence of a direct physical interaction between P311 and Rac1, further supporting the notion that P311 activation of Rac1 is mediated by intermediate soluble protein(s). In summary, these findings highlight the importance of P311 in the regulation of glioma cell migration. Importantly, we believe that the nonphosphorylated form of P311 on S59 results in increased protein stability, which subsequently promotes cytoskeleton dynamics essential for migration. We further speculate that P311 turnover in cells may impact the regulated action of actin-binding proteins interacting with signaling molecules such as Rac1. Thus, understanding the biologic role of P311 and its potential effectors is likely to open new possibilities for therapeutic interventions aimed at invading glioma cells.
